Cigalah Group agreed to acquire 51% stake in Alpha Pharma L.L.C. from Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR) on June 16, 2021. Transaction is subject to antitrust approval General Authority for Competition in the Kingdom of Saudi Arabia which was received during the current period. The transaction is expected to complete in third quarter of 2021.